Health Catalyst Q4 2023 GAAP EPS $0.02, Sales $75.08M Beat $73.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Health Catalyst (HCAT) reported Q4 2023 earnings of $0.02 per share with sales of $75.08M, surpassing the $73.60M estimate. This represents an 8.56% increase over the previous year's sales of $69.16M.
February 22, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Health Catalyst reported a positive Q4 2023 earnings surprise with a slight EPS and a significant sales beat, indicating strong performance.
HCAT's earnings beat and sales growth are significant indicators of the company's strong performance and operational efficiency. This positive news is likely to instill investor confidence and could lead to a short-term uptick in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100